Over a period of 5 years, OBJ has studied the suitability of a wide range of therapeutic and cosmetic modules for magnetic enhanced delivery which in turn inform the feasibility of developing products that utilise that technology.
In Vitro Diffusion
The following drugs and ingredients have been evaluated for their suitability to magnetic enhanced delivery in university studies using Franz type diffusion cells and excised human epidermis
The following drugs and ingredients have been evalu- ated for their suitability for magne c enhanced delivery in University studies using Franz type di usion cells and excised human epidermis
ALA hydrochloride Ca eine Ibuprofen Prilocaine Hydrochloride Lidocaine Hydrochloride ß-estradiol
Dipep de Ala-Trp Testosterone Tetracaine Hydrochloride Diclofenac (used in Vultaren) sodium Diclofenac diethylammonium salt Carbamide Peroxide
Because OBJ has stated that there are Two leading Anti-inflammatory product companies
and seeing as we already believe Nurofen could be one of them and we have been informed that Vultaren has shown interest then in my opinion only, they maybe the two major companies OBJ is referring too
But more importantly RB (Reckitt Benckiser) have stated in their latest FINANCIAL REPORT that in H2 16 (which is now) that they will be releasing an upgraded nurofen Gel that will have pain relief for up to 8 hours (the current gel only lasts for 4 hours)…SO IS THIS THE NEXT BIG NEWS ITEM the cracked coconut, after all ABDM has shared that Jeff believes this could be out pre christmas hmm and is this why Glyn brought the AGM one month forward? So as to have more time afterwards to gain more investor attention….
hmmm this is All My Opinion Only... Do your own research

OBJ Price at posting:
7.4¢ Sentiment: Buy Disclosure: Held
(20min delay)